Konstantinos Aliferis

1 Patent

• US123258792025

  Methods for Predicting a Response to Bevacizumab or Platinum-based Chemotherapy or Both in Patients with Ovarian Cancer

  REGENTS OF THE UNIVERSITY OF MINNESOTA

  0 cites